Nembutal Sodium (Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.))


Welcome to the PulseAid listing for the Nembutal Sodium drug offered from Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.). This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
NON-PROPRIETARY NAME: pentobarbital sodium
SUBSTANCE NAME: PENTOBARBITAL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1973-09-19
END MARKETING DATE: 0000-00-00


Nembutal Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNembutal Sodium from Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
LABELER NAME: Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
DEA SCHEDULE: CII
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 1973-09-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76478-501_d2e78e41-8a39-42ca-a6a4-375b5db85635
PRODUCT NDC: 76478-501
APPLICATION NUMBER: ANDA083246

Other PENTOBARBITAL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)Nembutal Sodium
Sagent Pharmaceuticalspentobarbital sodium